Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Ana
Martínez
Publicaciones en las que colabora con Ana Martínez (13)
2023
-
Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts
International Journal of Molecular Sciences, Vol. 24, Núm. 3
-
N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483
2022
-
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations
International Journal of Molecular Sciences, Vol. 23, Núm. 20
-
Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules
Antioxidants, Vol. 11, Núm. 7
-
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy
Journal of Medicinal Chemistry, Vol. 65, Núm. 2, pp. 1585-1607
2021
-
Molecular alterations in sporadic and sod1-als immortalized lymphocytes: Towards a personalized therapy
International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-17
-
Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis
European Journal of Medicinal Chemistry, Vol. 210
-
Tideglusib, a non-atp competitive inhibitor of gsk-3as a drug candidate for the treatment of amyotrophic lateral sclerosis
International Journal of Molecular Sciences, Vol. 22, Núm. 16
2020
-
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
Scientific Reports, Vol. 10, Núm. 1
2019
-
Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library
Nature Communications, Vol. 10, Núm. 1
2018
-
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors
European Journal of Medicinal Chemistry, Vol. 145, pp. 431-444
-
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
Molecular Neurodegeneration, Vol. 13, Núm. 1
2012
-
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model
European Journal of Medicinal Chemistry, Vol. 47, Núm. 1, pp. 175-185